BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9660431)

  • 1. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S; Affinito P; Tommaselli GA; Nappi C
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
    Palomba S; Affinito P; Di Carlo C; Bifulco G; Nappi C
    Fertil Steril; 1999 Nov; 72(5):889-95. PubMed ID: 10560995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
    Palomba S; Morelli M; Di Carlo C; Noia R; Pellicano M; Zullo F
    Fertil Steril; 2002 Jul; 78(1):63-8. PubMed ID: 12095492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
    Palomba S; Pellicano M; Affinito P; Di Carlo C; Zullo F; Nappi C
    Fertil Steril; 2001 Feb; 75(2):429-33. PubMed ID: 11172852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-back therapy with GnRH analogues for uterine fibroids.
    Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
    Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
    Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
    Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
    J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of add-back therapy with tibolone on myoma uteri.
    Göçmen A; Kara IH; Karaca M
    Clin Exp Obstet Gynecol; 2002; 29(3):222-4. PubMed ID: 12519049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.
    Scialli AR; Levi AJ
    Fertil Steril; 2000 Sep; 74(3):540-6. PubMed ID: 10973652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
    Di Carlo C; Palomba S; Tommaselli GA; Guida M; Di Spiezio Sardo A; Nappi C
    Fertil Steril; 2001 Feb; 75(2):380-4. PubMed ID: 11172843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
    Di Lieto A; De Falco M; Mansueto G; De Rosa G; Pollio F; Staibano S
    Steroids; 2005 Feb; 70(2):95-102. PubMed ID: 15631865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata.
    Nakayama H; Yano T; Sagara Y; Kikuchi A; Ando K; Wang Y; Watanabe M; Matsumi H; Osuga Y; Momoeda M; Taketani Y
    Gynecol Endocrinol; 1999 Dec; 13(6):382-9. PubMed ID: 10685331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
    Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ipriflavone in preventing adverse effects of leuprolide.
    Somekawa Y; Chiguchi M; Ishibashi T; Wakana K; Aso T
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3202-6. PubMed ID: 11443189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.